This website uses technical, customisation and analytical cookies, both first-party and third-party, to anonymously facilitate browsing and analyse statistics on use of the website. Learn more
Stanford Graduate School of Business (USA)
-
Novartis’ Gilenya: Navigating the Interplay Between Drug Innovation, Pricing, and Reimbursement in Different Countries’ Health Care Systems - Teaching Note
Chess, R; Luthre, JTeaching Note SGSB-E489TN-EEntrepreneurshipInternational healthcare and reimbursement systems underwent a radical transformation in the 2000s, resulting from growing financial pressures incited by economic depression and a steady rise in healthcare spending. This phenomenon was most pronounced in the United States, where the health-spending share of GDP rose from five percent in 1960 to 17.9 percent in 2011. In Organization for Economic Co-operation and Development (OECD) countries on a...Starting at €0.00
-
Target: Creating a Data-Driven Product Management Organization
Siegel, Robert; Kingbo, DavidCase SGSB-SM308-EStrategyAs retail shopping has changed with the rise of e-commerce, Target Corporate, one of the largest retail stores in the United States, made the strategic decision to invest in developing a core data science and technology team to remain competitive in its physical and online shopping experiences. The company hired a team of technologists who initially worked at enhancing the company’s digital and mobile solutions, but soon began influencing the com...Starting at €8.20
-
Target: Creating a Data-Driven Product Management Organization
Siegel, Robert; Kingbo, DavidCase SGSB-SM308 Spanish VersionStrategyAs retail shopping has changed with the rise of e-commerce, Target Corporate, one of the largest retail stores in the United States, made the strategic decision to invest in developing a core data science and technology team to remain competitive in its physical and online shopping experiences. The company hired a team of technologists who initially worked at enhancing the company’s digital and mobile solutions, but soon began influencing the com...Starting at €8.20
-
Novartis’ Gilenya: Navigating the Interplay Between Drug Innovation, Pricing, and Reimbursement in Different Countries’ Health Care Systems
Chess, R; Luthre, JCase SGSB-E489-EEntrepreneurshipInternational healthcare and reimbursement systems underwent a radical transformation in the 2000s, resulting from growing financial pressures incited by economic depression and a steady rise in healthcare spending. This phenomenon was most pronounced in the United States, where the health-spending share of GDP rose from five percent in 1960 to 17.9 percent in 2011. In Organization for Economic Co-operation and Development (OECD) countries on a...Starting at €8.20